Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach

Steven A. Carr(Broad Institute), Susan E. Abbatiello(Broad Institute), Bradley L. Ackermann(Eli Lilly (United States)), Christoph H. Borchers(ETH Zurich), Bruno Domon, Eric W. Deutsch(LabCorp (United States)), Russell P. Grant(LabCorp (United States)), Andrew N. Hoofnagle(University of Washington), Ruth Hüttenhain(University of California, San Francisco), John M. Koomen(Moffitt Cancer Center), D.C. Liebler(Vanderbilt University), Tao Liu(Pacific Northwest National Laboratory), Brendan MacLean(University of Washington), D.R. Mani(Broad Institute), Elizabeth Mansfield(United States Food and Drug Administration), Hendrik Neubert(Pfizer (United States)), Amanda G. Paulovich(Fred Hutch Cancer Center), Lukas Reiter(Biognosys (Switzerland)), Olga Vitek(Purdue University West Lafayette), Ruedi Aebersold(ETH Zurich), Leigh Anderson(ETH Zurich), Robert A. Bethem(Marin Community Foundation), Josip Blonder(National Institutes of Health), Emily S. Boja(National Institutes of Health), Julianne Cook Botelho(Centers for Disease Control and Prevention), Michael S. Boyne(United States Food and Drug Administration), Ralph Bradshaw(University of California, San Francisco), Alma L. Burlingame(University of California, San Francisco), Daniel W. Chan(Johns Hopkins University), Hasmik Keshishian(Broad Institute), Eric Kuhn(Broad Institute), Christopher R. Kinsinger(National Institutes of Health), Jerry Lee(Johns Hopkins University), Sang‐Won Lee(Korea University), Robert L. Moritz(Institute for Systems Biology), Juan A. Osés-Prieto(University of California, San Francisco), Nader Rifai(Boston Children's Hospital), James Ritchie(Emory University), Henry Rodriguez(National Institutes of Health), Pothur R. Srinivas(National Heart Lung and Blood Institute), R. Reid Townsend(Washington University in St. Louis), Jennifer E. Van Eyk(Johns Hopkins University), Gordon Whiteley(Leidos (United States)), Arun P. Wiita(University of California, San Francisco), Susan T. Weintraub(The University of Texas Health Science Center at San Antonio)
Molecular & Cellular Proteomics
January 17, 2014
Cited by 555Open Access
Full Text

Abstract

Adoption of targeted mass spectrometry (MS) approaches such as multiple reaction monitoring (MRM) to study biological and biomedical questions is well underway in the proteomics community. Successful application depends on the ability to generate reliable assays that uniquely and confidently identify target peptides in a sample. Unfortunately, there is a wide range of criteria being applied to say that an assay has been successfully developed. There is no consensus on what criteria are acceptable and little understanding of the impact of variable criteria on the quality of the results generated. Publications describing targeted MS assays for peptides frequently do not contain sufficient information for readers to establish confidence that the tests work as intended or to be able to apply the tests described in their own labs. Guidance must be developed so that targeted MS assays with established performance can be made widely distributed and applied by many labs worldwide. To begin to address the problems and their solutions, a workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays. Participants discussed the analytical goals of their experiments and the experimental evidence needed to establish that the assays they develop work as intended and are achieving the required levels of performance. Using this "fit-for-purpose" approach, the group defined three tiers of assays distinguished by their performance and extent of analytical characterization. Computational and statistical tools useful for the analysis of targeted MS results were described. Participants also detailed the information that authors need to provide in their manuscripts to enable reviewers and readers to clearly understand what procedures were performed and to evaluate the reliability of the peptide or protein quantification measurements reported. This paper presents a summary of the meeting and recommendations.


Related Papers

No related papers found

Powered by citation graph analysis